Literature DB >> 7964682

PET studies in progressive supranuclear palsy.

D J Brooks1.   

Abstract

Functional imaging (PET and SPECT) can be used to non-invasively demonstrate the patterns of metabolic and dopaminergic dysfunction associated with progressive supranuclear palsy. In this chapter the findings of published functional imaging studies are reviewed and the value of PET for distinguishing between the various degenerative causes of parkinsonism is discussed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7964682     DOI： 10.1007/978-3-7091-6641-3_10

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN： 0303-6995


  2 in total

1.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Authors:  I Litvan; C A Mangone; A McKee; M Verny; A Parsa; K Jellinger; L D'Olhaberriague; K R Chaudhuri; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

2.  Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study.

Authors:  Y F Tai; R L Ahsan; J G de Yébenes; N Pavese; D J Brooks; P Piccini
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.